ArticleEuropean journal of medical research2025
DDX3X promotes endoplasmic reticulum protein reprogramming via interaction with ERN1 to amplify cerebral ischemia/reperfusion injury.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundReperfusion therapy is a critical intervention to salvage acute cerebral ischemia. However, reperfusion itself induces cerebral ischemia/reperfusion (I/R) injury. Recent evidence suggests that DEAD-box helicase 3, X-linked (DDX3X) and Endoplasmic Reticulum to Nucleus Signaling 1 (ERN1) play pivotal roles in various diseases, particularly those affecting the nervous system. However, the exact roles of DDX3X and ERN1 in cerebral I/R injury remain unclear.
methodsWe used Sprague-Dawley (SD) rats subjected to middle cerebral artery occlusion (MCAO) surgery and PC12 cells exposed to oxygen-glucose deprivation/reoxygenation (OGD/R) to establish cerebral I/R injury models. Western blotting, immunohistochemistry, and co-immunoprecipitation were employed to assess the expression and interaction of DDX3X and ERN1. CCK-8 assay and flow cytometry were used to evaluate cell viability and apoptosis. Western blotting was performed to measure key endoplasmic reticulum stress (ERS) markers and downstream targets. Pro-inflammatory cytokines were quantified by ELISA.
resultsDDX3X and ERN1 were significantly upregulated in both OGD/R-treated PC12 cells and MCAO rat brain tissue. Importantly, DDX3X was shown to positively regulate ERN1 expression, leading to increased apoptosis, ERS, oxidative stress, and inflammation in both cellular and animal models. These processes collectively exacerbated cerebral injury, reinforcing the pathological role of DDX3X and ERN1 interaction in the progression of cerebral I/R injury.
conclusionDDX3X enhances cerebral I/R injury by interacting with ERN1, which triggers the reprogramming of endoplasmic reticulum protein responses, amplifying ERS, apoptosis, and inflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.